VEAT Notice for the Provision of Alloseq Tx17 NGS HLA Testing Kits

Concepts

• blood testing reagents
• manchester
• ngs hla testing kits
• alloseq tx17 ngs hla testing kits
• alloseq kits
• alloseq
• testing
• ngs
• tx17
• hla

Location

MANCHESTER

Description

Manchester University NHS Foundation Trust intends to award a contract to MC Diagnostics for the provision of Alloseq Tx17 NGS HLA Testing Kits. Alloseq is a Trademark of CareDx who have signed a distribution agreement with MC Diagnostics, who are based in the UK. Alloseq kits are compatible with Illumina MiSeq sequencing equipment previously procured. As such, a negotiated procedure without prior publication will be followed and is believed to be justified under section 32(2) (b) (ii) of the Public Contracts Regulations 2015 - 'competition is absent for technical reasons'.

Total Quantity or Scope

The estimated total value for this contract is £714,240, with a total maximum term of 18 months, made up of 12 months initial term with a further 6 month extension. This aligns to the equipment contract.

Award Detail

Renewal Options

Manchester University NHS Foundation Trust is a able to extend the contract for a further 6 months.

CPV Codes

• 33696200 - Blood-testing reagents

Indicators

• Options are available.

Legal Justification

Manchester University NHS Foundation Trust intends to award a contract to MC Diagnostics for the provision of Alloseq Tx17 NGS HLA Testing Kits. Alloseq is a Trademark of CareDx who have signed a distribution agreement with MC Diagnostics, who are based in the UK. Alloseq kits are compatible with Illumina MiSeq sequencing equipment previously procured. As such, a negotiated procedure without prior publication will be followed and is believed to be justified under section 32(2) (b) (ii) of the Public Contracts Regulations 2015 - 'competition is absent for technical reasons'.